NCT04201262 2025-10-14
An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
Clinical Trials
10 trialsNCT02003144 2022-08-23
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT00304291 2020-12-28
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
State University of New York at Buffalo
Phase 4 Completed
NCT02591901 2020-03-18
PReSuTINeB
Buckinghamshire Healthcare NHS Trust
Phase 2 Completed
NCT02276963 2019-06-06
Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
Johns Hopkins University
Phase 1 Completed
NCT02341950 2019-02-22
Clinical Trial of a Serious Game for Individuals With SCI/D
University of Michigan
Phase NA Completed
NCT03138421 2019-01-25
Central Pain Study for ABX-1431
Abide Therapeutics
Phase 1 Completed
NCT02166346 2018-04-17
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
Johns Hopkins University
Phase 2 Completed
NCT00179478 2017-09-06
CHAMPIONS10
Beth Israel Deaconess Medical Center
Phase 4 Completed
NCT00501748 2011-09-27
Safety and Tolerability of Rituximab in Neuromyelitis Optica
University of California, San Francisco
Phase 1 Completed